{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T05:45:41Z","timestamp":1782452741471,"version":"3.54.5"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2015,2,19]],"date-time":"2015-02-19T00:00:00Z","timestamp":1424304000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1038\/hr.2015.14","type":"journal-article","created":{"date-parts":[[2015,2,19]],"date-time":"2015-02-19T06:54:30Z","timestamp":1424328870000},"page":"463-470","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":58,"title":["Association between renal iron accumulation and renal interstitial fibrosis in a rat model of chronic kidney disease"],"prefix":"10.1038","volume":"38","author":[{"given":"Yoshiro","family":"Naito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aya","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisashi","family":"Sawada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makiko","family":"Oboshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiro","family":"Iwasaku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshitaka","family":"Okuhara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Morisawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiyo","family":"Eguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Hirotani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tohru","family":"Masuyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,2,19]]},"reference":[{"key":"BFhr201514_CR1","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1056\/NEJMoa041031","volume":"351","author":"AS Go","year":"2004","unstructured":"Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY . Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351: 1296\u20131305.","journal-title":"N Engl J Med"},{"key":"BFhr201514_CR2","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/ki.2011.77","volume":"80","author":"SE Quaggin","year":"2011","unstructured":"Quaggin SE, Kapus A . Scar wars: mapping the fate of epithelial-mesenchymal-myofibroblast transition. Kidney Int 2011; 80: 41\u201350.","journal-title":"Kidney Int"},{"key":"BFhr201514_CR3","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/S0272-6386(12)70222-6","volume":"20","author":"BJ Nankivell","year":"1992","unstructured":"Nankivell BJ, Boadle RA, Harris DC . Iron accumulation in human chronic renal disease. Am J Kidney Dis 1992; 20: 580\u2013584.","journal-title":"Am J Kidney Dis"},{"key":"BFhr201514_CR4","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1053\/ajkd.2001.28593","volume":"38","author":"H Wang","year":"2001","unstructured":"Wang H, Nishiya K, Ito H, Hosokawa T, Hashimoto K, Moriki T . Iron deposition in renal biopsy specimens from patients with kidney diseases. Am J Kidney Dis 2001; 38: 1038\u20131044.","journal-title":"Am J Kidney Dis"},{"key":"BFhr201514_CR5","doi-asserted-by":"publisher","first-page":"3631","DOI":"10.1681\/ASN.2005050522","volume":"16","author":"Y Izuhara","year":"2005","unstructured":"Izuhara Y, Nangaku M, Inagi R, Tominaga N, Aizawa T, Kurokawa K, van Ypersele de Strihou C, Miyata T . Renoprotective properties of angiotensin receptor blockers beyond blood pressure lowering. J Am Soc Nephrol 2005; 16: 3631\u20133641.","journal-title":"J Am Soc Nephrol"},{"key":"BFhr201514_CR6","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1681\/ASN.V481598","volume":"4","author":"BJ Nankivell","year":"1994","unstructured":"Nankivell BJ, Chen J, Boadle RA, Harris DC . The role of tubular iron accumulation in the remnant kidney. J Am Soc Nephrol 1994; 4: 1598\u20131607.","journal-title":"J Am Soc Nephrol"},{"key":"BFhr201514_CR7","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1111\/j.1440-1681.1994.tb02472.x","volume":"21","author":"DC Harris","year":"1994","unstructured":"Harris DC, Tay C, Nankivell BJ . Lysosomal iron accumulation and tubular damage in rat puromycin nephrosis and ageing. Clin Exp Pharmacol Physiol 1994; 21: 73\u201381.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"BFhr201514_CR8","doi-asserted-by":"publisher","first-page":"e75906","DOI":"10.1371\/journal.pone.0075906","volume":"8","author":"Y Naito","year":"2013","unstructured":"Naito Y, Sawada H, Oboshi M, Fujii A, Hirotani S, Iwasaku T, Okuhara Y, Eguchi A, Morisawa D, Ohyanagi M, Tsujino T, Masuyama T . Increased renal iron accumulation in hypertensive nephropathy of salt-loaded hypertensive rats. PLoS ONE 2013; 8: e75906.","journal-title":"PLoS ONE"},{"key":"BFhr201514_CR9","first-page":"H1901","volume":"259","author":"R Bolli","year":"1990","unstructured":"Bolli R, Patel BS, Jeroudi MO, Li XY, Triana JF, Lai EK, McCay PB . Iron-mediated radical reactions upon reperfusion contribute to myocardial \"stunning\". Am J Physiol 1990; 259: H1901\u2013H1911.","journal-title":"Am J Physiol"},{"key":"BFhr201514_CR10","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/0891-5849(89)90099-3","volume":"7","author":"BR Reddy","year":"1989","unstructured":"Reddy BR, Kloner RA, Przyklenk K . Early treatment with deferoxamine limits myocardial ischemic\/reperfusion injury. Free Radic Biol Med 1989; 7: 45\u201352.","journal-title":"Free Radic Biol Med"},{"key":"BFhr201514_CR11","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1097\/01.CCM.0000142699.54266.D9","volume":"32","author":"C Ritter","year":"2004","unstructured":"Ritter C, Reinke A, Andrades M, Martins MR, Rocha J, Menna-Barreto S, Quevedo J, Moreira JC, Dal-Pizzol F . Protective effect of N-acetylcysteine and deferoxamine on carbon tetrachloride-induced acute hepatic failure in rats. Crit Care Med 2004; 32: 2079\u20132083.","journal-title":"Crit Care Med"},{"key":"BFhr201514_CR12","first-page":"576","volume":"21","author":"F Bulucu","year":"2008","unstructured":"Bulucu F, Oktenli C, Kenar L, Ocal R, Koc B, Inal V, Yamanel L, Yaman H, Sanisoglu YS, Aydin A . Efficacy of deferoxamine, N-acetylcysteine and selenium treatments in rats with adriamycin-induced nephrotic syndrome. J Nephrol 2008; 21: 576\u2013583.","journal-title":"J Nephrol"},{"key":"BFhr201514_CR13","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.tox.2011.11.003","volume":"291","author":"E Molina-Jij\u00f3n","year":"2012","unstructured":"Molina-Jij\u00f3n E, Zarco-M\u00e1rquez G, Medina-Campos ON, Zatara\u00edn-Barr\u00f3n ZL, Hern\u00e1ndez-Pando R, Pinz\u00f3n E, Zavaleta RM, Tapia E, Pedraza-Chaverri J . Deferoxamine pretreatment prevents Cr(VI)-induced nephrotoxicity and oxidant stress: role of Cr(VI) chelation. Toxicology 2012; 291: 93\u2013101.","journal-title":"Toxicology"},{"key":"BFhr201514_CR14","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3109\/15376516.2012.730558","volume":"23","author":"MM Rajapurkar","year":"2013","unstructured":"Rajapurkar MM, Hegde U, Bhattacharya A, Alam MG, Shah SV . Effect of deferiprone, an oral iron chelator, in diabetic and non-diabetic glomerular disease. Toxicol Mech Methods 2013; 23: 5\u201310.","journal-title":"Toxicol Mech Methods"},{"key":"BFhr201514_CR15","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.1097\/HJH.0b013e3283581a64","volume":"30","author":"Y Naito","year":"2012","unstructured":"Naito Y, Fujii A, Sawada H, Hirotani S, Iwasaku T, Eguchi A, Ohyanagi M, Tsujino T, Masuyama T . Effect of iron restriction on renal damage and mineralocorticoid receptor signaling in a rat model of chronic kidney disease. J Hypetens 2012; 30: 2192\u20132201.","journal-title":"J Hypetens"},{"key":"BFhr201514_CR16","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1161\/HYPERTENSIONAHA.110.159681","volume":"57","author":"Y Naito","year":"2011","unstructured":"Naito Y, Hirotani S, Sawada H, Akahori H, Tsujino T, Masuyama T . Dietary iron restriction prevents hypertensive cardiovascular remodeling in Dahl salt-sensitive rats. Hypertension 2011; 57: 497\u2013504.","journal-title":"Hypertension"},{"key":"BFhr201514_CR17","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/hr.2012.204","volume":"36","author":"X Chen","year":"2013","unstructured":"Chen X, Mori T, Guo Q, Hu C, Ohsaki Y, Yoneki Y, Zhu W, Jiang Y, Endo S, Nakayama K, Ogawa S, Nakayama M, Miyata T, Ito S . Carbonyl stress induces hypertension and cardio-renal vascular injury in Dahl salt-sensitive rats. Hypertens Res 2013; 36: 361\u2013367.","journal-title":"Hypertens Res"},{"key":"BFhr201514_CR18","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1097\/HJH.0b013e328360381d","volume":"31","author":"Y Naito","year":"2013","unstructured":"Naito Y, Fujii A, Sawada H, Hirotani S, Iwasaku T, Okuhara Y, Eguchi A, Ohyanagi M, Tsujino T, Masuyama T . Dietary iron restriction prevents further deterioration of renal damage in a chronic kidney disease rat model. J Hypetens 2013; 31: 1203\u20131213.","journal-title":"J Hypetens"},{"key":"BFhr201514_CR19","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1038\/hr.2014.79","volume":"37","author":"L Ho\u0161kov\u00e1","year":"2014","unstructured":"Ho\u0161kov\u00e1 L, M\u00e1lek I, Kautzner J, Honsov\u00e1 E, van Dokkum RP, Huskov\u00e1 Z, Vojt\u00ed\u0161kov\u00e1 A, Varcabov\u00e1 S, Cervenka L, Kopkan L . Tacrolimus-induced hypertension and nephrotoxicity in Fawn-Hooded rats are attenuated by dual inhibition of renin-angiotensin system. Hypertens Res 2014; 37: 724\u2013732.","journal-title":"Hypertens Res"},{"key":"BFhr201514_CR20","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1172\/JCI200317647","volume":"112","author":"E Pillebout","year":"2003","unstructured":"Pillebout E, Weitzman JB, Burtin M, Martino C, Federici P, Yaniv M, Friedlander G, Terzi F . JunD protects against chronic kidney disease by regulating paracrine mitogens. J Clin Invest 2003; 112: 843\u2013852.","journal-title":"J Clin Invest"},{"key":"BFhr201514_CR21","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1172\/JCI200319270","volume":"112","author":"M Sato","year":"2003","unstructured":"Sato M, Muragaki Y, Saika S, Roberts AB, Ooshima A . Targeted disruption of TGF-beta1\/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction. J Clin Invest 2003; 112: 1486\u20131494.","journal-title":"J Clin Invest"},{"key":"BFhr201514_CR22","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1111\/j.1523-1755.2004.00465.x","volume":"65","author":"BP Oberg","year":"2004","unstructured":"Oberg BP, McMenamin E, Lucas FL, McMonagle E, Morrow J, Ikizler TA, Himmelfarb J . Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney disease. Kidney Int 2004; 65: 1009\u20131016.","journal-title":"Kidney Int"},{"key":"BFhr201514_CR23","doi-asserted-by":"publisher","first-page":"c81","DOI":"10.1159\/000314656","volume":"116","author":"B Rodr\u00edguez-Iturbe","year":"2010","unstructured":"Rodr\u00edguez-Iturbe B, Garc\u00eda Garc\u00eda G . The role of tubulointerstitial inflammation in the progression of chronic renal failure. Nephron Clin Pract 2010; 116: c81\u2013c88.","journal-title":"Nephron Clin Pract"},{"key":"BFhr201514_CR24","doi-asserted-by":"publisher","first-page":"4065","DOI":"10.1172\/JCI42004","volume":"120","author":"A Viau","year":"2010","unstructured":"Viau A, El Karoui K, Laouari D, Burtin M, Nguyen C, Mori K, Pillebout E, Berger T, Mak TW, Knebelmann B, Friedlander G, Barasch J, Terzi F . Lipocalin 2 is essential for chronic kidney disease progression in mice and humans. J Clin Invest 2010; 120: 4065\u20134076.","journal-title":"J Clin Invest"},{"key":"BFhr201514_CR25","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/ki.2011.313","volume":"81","author":"N Goraya","year":"2012","unstructured":"Goraya N, Simoni J, Jo C, Wesson DE . Dietary acid reduction with fruits and vegetables or bicarbonate attenuates kidney injury in patients with a moderately reduced glomerular filtration rate due to hypertensive nephropathy. Kidney Int 2012; 81: 86\u201393.","journal-title":"Kidney Int"},{"key":"BFhr201514_CR26","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/nrneph.2013.98","volume":"9","author":"AM Martines","year":"2013","unstructured":"Martines AM, Masereeuw R, Tjalsma H, Hoenderop JG, Wetzels JF, Swinkels DW . Iron metabolism in the pathogenesis of iron-induced kidney injury. Nat Rev Nephrol 2013; 9: 385\u2013398.","journal-title":"Nat Rev Nephrol"},{"key":"BFhr201514_CR27","doi-asserted-by":"publisher","first-page":"e89355","DOI":"10.1371\/journal.pone.0089355","volume":"9","author":"Y Ikeda","year":"2014","unstructured":"Ikeda Y, Ozono I, Tajima S, Imao M, Horinouchi Y, Izawa-Ishizawa Y, Kihira Y, Miyamoto L, Ishizawa K, Tsuchiya K, Tamaki T . Iron chelation by deferoxamine prevents renal interstitial fibrosis in mice with unilateral ureteral obstruction. PLoS ONE 2014; 9: e89355.","journal-title":"PLoS ONE"},{"key":"BFhr201514_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0272-6386(12)80312-X","volume":"20","author":"KA Nath","year":"1992","unstructured":"Nath KA . Tubulointerstitial changes as a major determinant in the progression of renal damage. Am J Kidney Dis 1992; 20: 1\u20137.","journal-title":"Am J Kidney Dis"},{"key":"BFhr201514_CR29","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1089\/ars.2006.8.1597","volume":"8","author":"PS Gill","year":"2006","unstructured":"Gill PS, Wilcox CS . NADPH oxidases in the kidney. Antioxid Redox Signal 2006; 8: 1597\u20131607.","journal-title":"Antioxid Redox Signal"},{"key":"BFhr201514_CR30","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1111\/nep.12035","volume":"18","author":"GL Maker","year":"2013","unstructured":"Maker GL, Siva B, Batty KT, Trengove RD, Ferrari P, Olynyk JK . Pharmacokinetics and safety of deferasirox in subjects with chronic kidney disease undergoing haemodialysis. Nephrology (Carlton) 2013; 18: 188\u2013193.","journal-title":"Nephrology (Carlton)"},{"key":"BFhr201514_CR31","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1007\/s00277-013-1703-7","volume":"92","author":"M Breccia","year":"2013","unstructured":"Breccia M, Alimena G . Efficacy and safety of deferasirox in myelodysplastic syndromes. Ann Hematol 2013; 92: 863\u2013870.","journal-title":"Ann Hematol"},{"key":"BFhr201514_CR32","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1517\/14740338.2010.497138","volume":"9","author":"GJ Kontoghiorghes","year":"2010","unstructured":"Kontoghiorghes GJ . Introduction of higher doses of deferasirox: better efficacy but not effective iron removal from the heart and increased risks of serious toxicities. Expert Opin Drug Saf 2010; 9: 633\u2013641.","journal-title":"Expert Opin Drug Saf"},{"key":"BFhr201514_CR33","first-page":"177","volume":"112","author":"N Murphy","year":"2013","unstructured":"Murphy N, Elramah M, Vats H, Zhong W, Chan MR . A case report of deferasirox-induced kidney injury and Fanconi syndrome. WMJ 2013; 112: 177\u2013180.","journal-title":"WMJ"},{"key":"BFhr201514_CR34","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.toxlet.2011.03.018","volume":"203","author":"PD S\u00e1nchez-Gonz\u00e1lez","year":"2011","unstructured":"S\u00e1nchez-Gonz\u00e1lez PD, L\u00f3pez-Hernandez FJ, Morales AI, Mac\u00edas-Nu\u00f1ez JF, L\u00f3pez-Novoa JM . Effects of deferasirox on renal function and renal epithelial cell death. Toxicol Lett 2011; 203: 154\u2013161.","journal-title":"Toxicol Lett"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/hr201514.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/hr201514","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/hr201514.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T17:15:06Z","timestamp":1684430106000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/hr201514"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,19]]},"references-count":34,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["BFhr201514"],"URL":"https:\/\/doi.org\/10.1038\/hr.2015.14","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,19]]},"assertion":[{"value":"4 July 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2014","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2015","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2015","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"There authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}